Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children

Neurotoxicology and Teratology

Volumn 34, Issue 5, 2012, Pages 513-521

  Woods, James S ^a   Heyer, Nicholas J ^b   Echeverria, Diana ^a   Russo, Joan E ^c   Martin, Michael D ^a   Bernardo, Mario F ^d   Luis, Henrique S ^d   Vaz, Lurdes ^d   Farin, Federico M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d FACULDADE DE MEDICINA DENTÁRIA   (Portugal)

Author keywords

Behavior; Children; CPOX4; Genetic polymorphism; Mercury; Neurotoxicity

Indexed keywords

COPROPORPHYRINOGEN OXIDASE; MERCURY;

ARTICLE; ATTENTION; CHILD; CONTROLLED STUDY; COPROPORPHYRINOGEN OXIDASE GENE; EXECUTIVE FUNCTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LEARNING; MALE; MEMORY; MENTAL PERFORMANCE; MOTOR PERFORMANCE; MUTATOR GENE; NEUROTOXICITY; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; URINE LEVEL; VISUAL ACUITY;

CHILD; CHILD BEHAVIOR; COPROPORPHYRINOGEN OXIDASE; DENTAL AMALGAM; FEMALE; HUMANS; MALE; MERCURY POISONING, NERVOUS SYSTEM; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; SEX FACTORS;

EID: 84864435732     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.06.004     Document Type: Article

References (54)

1. Baca-García E., Vaquero C., Diaz-Sastre C., Saiz-Ruiz J., Fernández-Piqueras J., de Leon J. A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 2002, 26:692-695.
2. Björklund O., Kahlström J., Salmi P., Ove Ögren S., Vahter M., Chen J.-C., et al. The effects of methylmercury on motor activity are sex- and age-dependent, and modulated by genetic deletion of adenosine receptors and caffeine administration. Toxicology 2007, 241:119-133.
3. Braun J.M., Kahn R.S., Froehlich T., Auinger P., Lanphear B.P. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006, 114:1904-1909.
4. Calabrese E.J. Toxic susceptibility: male/female differences 1985, Wiley-Interscience, New York.
5. Centers for disease control prevention National Health and Nutrition Examination Survey Available:, [15 May 2012]. http://www.cdc.gov/nchs/nhanes.htm.
6. Chamary J.V., Parmley J.L., Hurst L.D. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat Rev Genet 2006, 7:98-108.
7. Chernova T., Steinhert J.R., Richards P., Mistry R., Challiss R.A.J., Jukes-Jones R., et al. Early failure of N-methyl-d-aspartate receptors and deficient spine formation induced by reduction of regulatory heme in neurons. Mol Pharmacol 2011, 79:844-854.
8. Chernova T., Nicotera P., Smith A.G. Heme deficiency is associated with senescence and causes suppression of N-methyl-d-aspartate receptor subunits expression in primary cortical neurons. Mol Pharmacol 2006, 69:697-705.
9. Chugani D.C., Musik O., Behen M., Rothermel R., Janisse J.J., Lee J., Chugani H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999, 45:287-295.
10. Clarkson T.W. Three modern faces of mercury. Environ Health Perspect 2003, 110:11-23.
11. Counter S.A., Buchanan L.H. Mercury exposure in children: a review. Toxicol Appl Pharmacol 2004, 198:209-230.
12. Davidson P.W., Myers G.J., Weiss B. Mercury exposure and child development outcomes. Pediatrics 2004, 113(Suppl. 4):1023-1029.
13. DeRouen T.A., Leroux B.G., Martin M.D., Townes B.D., Woods J.S., Leitão J., Castro-Caldas A., Braveman N. Issues in the design and analysis of a randomized clinical trial to assess the safety of dental amalgam fillings in children. Control Clin Trials 2002, 23:301-320.
14. DeRouen T.A., Martin M.D., Leroux B.G., Townes B.D., Woods J.S., Leitão J., Castro-Caldas A., Luis H., Bernardo M., Rosenbaum G., Martins I.P. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA 2006, 295(15):1784-1792.
15. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003, 112:205-216.
16. 0: new distinctions between recent exposure and Hg body burden. FASEB J 1998, 12:971-980.
17. Echeverria D., Heyer N.J., Bittner A.C., Rohlman D., Woods J.S. Test-retest reliability and factor stability of the Behavioral Evaluation for Epidemiology Studies test battery. Percept Mot Skills 2002, 95:845-867.
18. Echeverria D., Woods J.S., Heyer N.J., Martin M.D., Rholman D., Farin F.M., et al. The association between serotonin transporter gene promoter polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans. J Toxicol Environ Health 2010, 73:552-569.
19. Echeverria D., Woods J.S., Heyer N.J., Rholman D., Farin F.M., Bittner A.C., et al. Chronic low-level mercury exposure, BDNF polymorphism, and associations with memory, attention and motor function. Neurotoxicol Teratol 2005, 27:781-796.
20. Echeverria D., Woods J.S., Heyer N.J., Rholman D., Farin F.M., Li T., et al. The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure, and neurobehavioral response in humans. Neurotoxicol Teratol 2006, 28:39-48.
21. Engström K.S., Strömberg U., Lundh T., Jonhansson I., Vessby B., Hallmans G., et al. Genetic variation in glutathione-related genes and body burden of methylmercury. Environ Health Perspect 2008, 116:734-739.
22. Evens C.C., Martin M.D., Woods J.S., Soares H.L., Bernardo M., Leitão J., et al. Examination of dietary methylmercury exposure in the Casa Pia study of the health effects of dental amalgams in children. J Toxicol Environ Health 2001, 64:521-530.
23. Faustman E.M., Silbernagel S.M., Fenske R.A., Burbacher T.M., Ponce R.A. Mechanisms underlying children's susceptibility to environmental toxicants. Environ Health Perspect 2000, 108(Suppl. 1):13-21.
24. Gaub M., Carlson C.L. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997, 36:1036-1045.
25. Gochfeld M. Framework for gender differences in human and animal toxicology. Environ Res 2007, 104:4-21.
26. Goering P.L., Galloway W.D., Clarkson T.W., Lorscheider F.L., Berlin M., Rowland A.S. Toxicity assessment of mercury vapor from dental amalgams. Fundam Appl Toxicol 1992, 19:319-329.
27. Gundacker C., Gencik M., Hengstschläger M. The relevance of individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: mercury and lead. Mutat Res 2010, 705:130-140.
28. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008, 33:3037-3045.
29. Heyer N.J., Echeverria D., Bittner A.C., Farin F.M., Garabedian C.C., Woods J.S. Chronic low-level mercury exposure, BDNF polymorphism and associations with self-reported symptoms and mood. Toxicol Sci 2004, 81:354-363.
30. Heyer N.J., Echeverria D., Farin F.M., Woods J.S. The association between serotonin transporter gene promoter polymorphism (5-HTTLPR), self-reported symptoms, and dental mercury exposure. J Toxicol Environ Health 2008, 71:1318-1326.
31. Heyer N.J., Echeverria D., Martin M.D., Farin F.M., Woods J.S. Catechol-O-methyltransferase (COMT) Val158Met functional polymorphism, dental mercury exposure, and self-reported symptoms and mood. J Toxicol Environ Health 2009, 72:599-609.
32. Hines R.N., Sargent D., Autrup H., Birnbaum L.S., Brent R.L., Doerrer N.G., et al. Approaches for assessing risk to sensitive populations: lessons learned from evaluating risk in the pediatric population. Toxicol Sci 2010, 113:4-26.
33. Kelada S.N., Costa-Mallen P., Costa L.G., Smith-Weller T., Franklin G.M., Swanson P.D., et al. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. Neurotoxicology 2002, 23:515-519.
34. Komar A.A. SNPs, silent but not invisible. Science 2007, 315:466-467.
35. Landrigan P.J., Goldman L.R. Children's vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. Health Aff 2011, 30:842-850.
36. Levy M., Schwartz S., Dijak M., Weber J.-P., Tardif R., Rouah F. Childhood urine mercury excretion: dental amalgam and fish consumption as exposure factors. Environ Res 2004, 94:283-290.
37. Li T., Woods J.S. Cloning, expression, and biochemical properties of CPOX4, a genetic variant of coproporphyrinogen oxidase that affects susceptibility to mercury toxicity in humans. Toxicol Sci 2009, 109:228-236.
38. Litman D.A., Correia M.A. l-Tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria?. Science 1983, 222:1031-1033.
39. Litman D.A., Correia M.A. Elevated brain tryptophan and enhanced 5-hydroxytryptamine turnover in acute hepatic heme deficiency: clinical implications. J Pharmacol Exp Ther 1985, 232:337-345.
40. Martins I.P., Castro-Caldas A., Townes B., Ferreira G., Rodrigues P., Marques S., et al. Age and sex difference in neurobehavioral performance: a study of Portuguese elementary school children. Int J Neurosci 2005, 115:1687-1709.
41. Pingree S.D., Simmonds P.L., Woods J.S. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats. Toxicol Sci 2001, 61:224-233.
42. Samochowiec J., Hajduc A., Samochowiec A., Horodnicki J., Stepien G., Grzywacz A., et al. Association of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res 2004, 128:21-26.
43. Sengupta A., Hon T., Zhang L. Heme deficiency suppresses the expression of key neuronal genes and causes neuronal cell death. Brain Res Mol Brain Res 2005, 137:23-30.
44. Slade P.D., Townes B.D., Rosenbaum G., Martins I.P., Luis H., Bernardo M., et al. The serial use of child neurocognitive tests: development versus practice effects. Psychol Assess 2008, 20:361-369.
45. Smith A.G., Raven E.L., Chernova T. The regulatory role of heme in neurons. Metallomics 2012, 3:955-962.
46. Suk W.A., Collman G.W. Genes and the environment: their impact on children's health. Environ Health Perspect 1998, 106(Suppl. 3):817-820.
47. Townes B.D., Rosenbaum G., Martin M.D., Martins I.P., Luis H., Bernardo M. A longitudinal factor analytic study of children's neurocognitive abilities. Int J Neurosci 2008, 118(7):1009-1023.
48. Townes B.D., Martins I.P., Castro-Caldas A., Rosenbaum G., DeRouen T. Repeat test scores on neurobehavioral measures over an eight-year period in a sample of Portuguese children. Int J Neurosci 2008, 118(1):79-93.
49. Vahter M., Åkesson A., Lidén C., Ceccatelli S., Berglund M. Genetic differences in the disposition and toxicity of metals. Environ Res 2007, 104:85-95.
50. Vahter M., Gochfeld M., Casati B., Thiruchelvam M., Falk-Filippson A., Kavlock R., et al. Implications of gender differences for human health risk assessment and toxicology. Environ Res 2007, 104:70-84.
51. Valentino R.J., Reyes B., Bockstaele E.V., Bangasser D. Molecular and cellular sex differences at the intersection of stress and arousal. Neuropharmacology 2012, 62:13-20.
52. Weiss B. Sexually dimorphic nonreproductive behaviors as indicators of endocrine disruption. Environ Health Perspect 2002, 110(Suppl. 3):387-391.
53. Woods J.S., Echeverria D., Heyer N.J., Simmonds P.L., Wilkerson J., Farin F.M. The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Toxicol Appl Pharmacol 2005, 206:113-120.
54. Woods J.S., Martin M.D., Leroux B.G., DeRouen T.A., Leitão J.G., Bernardo M., et al. The contribution of dental amalgam to urinary mercury excretion in children. Environ Health Perspect 2007, 115:527-1531.